Details for New Drug Application (NDA): 021044
✉ Email this page to a colleague
The generic ingredient in PALLADONE is hydromorphone hydrochloride. There are fourteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
Summary for 021044
Tradename: | PALLADONE |
Applicant: | Purdue Pharma Lp |
Ingredient: | hydromorphone hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021044
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 12MG | ||||
Approval Date: | Sep 24, 2004 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 16MG | ||||
Approval Date: | Sep 24, 2004 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 24MG | ||||
Approval Date: | Sep 24, 2004 | TE: | RLD: | No |
Expired US Patents for NDA 021044
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-001 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription